[go: up one dir, main page]

ATE424817T1 - Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung - Google Patents

Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung

Info

Publication number
ATE424817T1
ATE424817T1 AT01973897T AT01973897T ATE424817T1 AT E424817 T1 ATE424817 T1 AT E424817T1 AT 01973897 T AT01973897 T AT 01973897T AT 01973897 T AT01973897 T AT 01973897T AT E424817 T1 ATE424817 T1 AT E424817T1
Authority
AT
Austria
Prior art keywords
methods
compositions containing
containing aliphatic
aliphatic polyamines
topical analgesic
Prior art date
Application number
AT01973897T
Other languages
English (en)
Inventor
Alan Perlmutter
R Wickett
Original Assignee
Dermal Therapy Barbados Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermal Therapy Barbados Inc filed Critical Dermal Therapy Barbados Inc
Application granted granted Critical
Publication of ATE424817T1 publication Critical patent/ATE424817T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01973897T 2000-09-19 2001-09-19 Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung ATE424817T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23348800P 2000-09-19 2000-09-19

Publications (1)

Publication Number Publication Date
ATE424817T1 true ATE424817T1 (de) 2009-03-15

Family

ID=22877452

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01973897T ATE424817T1 (de) 2000-09-19 2001-09-19 Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung

Country Status (7)

Country Link
US (1) US20040039057A1 (de)
EP (1) EP1318801B1 (de)
AT (1) ATE424817T1 (de)
AU (1) AU2001293559A1 (de)
CA (1) CA2422531C (de)
DE (1) DE60137946D1 (de)
WO (1) WO2002024185A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038105A2 (en) * 2000-11-08 2002-05-16 Slil Biomedical Corporation Novel polyamine analog-amino acid conjugates useful as anticancer agents
WO2000066175A2 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Conjugates as therapies for cancer and prostate diseases
EP1698629A3 (de) * 1999-04-30 2006-11-29 Cellgate, Inc. Polyamine und ihre therapeutische Verwendung
US20030130356A1 (en) * 2001-10-16 2003-07-10 Slil Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
WO2008091161A1 (en) * 2007-01-26 2008-07-31 Fridtjof Bjerke Cosmetic composition containing spermine and emu oil
DE102008064214A1 (de) 2008-12-22 2010-06-24 Klosterfrau Berlin Gmbh Lokalanästhetikum zur Linderung von Brustschmerz
US8920831B2 (en) * 2011-06-20 2014-12-30 Hisamitsu Pharmaceutical Co., Inc. Lidocaine-containing hydrogel patch
RU2648441C2 (ru) * 2016-09-13 2018-03-26 Казимир Иосифович Пашкевич Средство для местной анестезии (варианты)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752620A (en) * 1986-11-21 1988-06-21 David Roberts Method of treating pain with urea and glyoxal compositions
IE903302A1 (en) * 1989-09-15 1991-04-10 Pehrom Pharmaceutical Corp Topical preparation for treatment of aphthous ulcers and¹other lesions
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5980918A (en) * 1997-10-24 1999-11-09 Brennen Medical, Inc. β-D-glucan topical composition
FR2775901B1 (fr) * 1998-03-13 2000-07-21 Logeais Labor Jacques Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments

Also Published As

Publication number Publication date
CA2422531A1 (en) 2002-03-28
EP1318801B1 (de) 2009-03-11
EP1318801A2 (de) 2003-06-18
WO2002024185A2 (en) 2002-03-28
AU2001293559A1 (en) 2002-04-02
WO2002024185A3 (en) 2002-09-06
CA2422531C (en) 2011-03-08
DE60137946D1 (de) 2009-04-23
US20040039057A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
ATE424817T1 (de) Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung
TR200201004T2 (tr) Monoamin reuptake önleyicileri olarak biaril eter türevleri
TR200200376T2 (tr) Aşırı şişmanlık tedavisi için planlanan ilaçların üretiminde monoamin oksidaz inhibitörlerinin kullanımı
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
ATE250977T1 (de) Nickel-enthaltender hydrierkatalysator und verfahren zu seiner herstellung
AR046933A1 (es) Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea
DE502004007919D1 (de) Hochfunktionelle, hochverzweigte polyharnstoffe
CY1106056T1 (el) Παραγωγα 2-αμινο-2-αλκυλ-5-επτενοϊκου και επτυνοϊκου οξεος χρησιμα σαν αναστολεις συνθασης νιτρικου οξειδιου
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
BR0005824A (pt) Sais de alquilespiroborato para uso em células eletroquìmicas
ATE395050T1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
SG152257A1 (en) Topical preparation containing ambroxol
DK1572178T3 (da) Behandling af mastalgi med 4-hydroxytamoxifen
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
Wong et al. Improving safety knowledge through training- the case of Hong Kong.
IS8546A (is) Samsetning deramsíklans og ópíóíða sem verkjadeyfandi lyfja
Zhdanova et al. Problem solution for exploitation of road structures at the Russian Far East northern areas
Yuan RESHUFFLING AN INDUSTRY
Tsuyoshi Some collaborative work between Japan and China focusing on desertification of grassland during the last 10 years based on questionnaires
Arabian et al. Removal of ammonium nitrogen and orthophosphate from urban wastewater by stabilized microalgae cells
Saffy Typed Document: Course Description
PEYVANDI et al. Comparative Analysis Of Using Electrocauter And Scalpel In Midine Laparotomy Patients Who Reffered Of Loghman Hakim Hospital (2012 To 2013)
Haghgoo et al. Remineralizing Effect of Topical NovaMin and Nano-Hydroxyapatite on Caries-Like Lesions in permanant Teeth
CN201219008Y (zh) 用于牌子固定的装置
MALEKNEZHAD et al. Effect of ultrasonic cleanser on base metal alloy to enamel bond strength after surface treatment by acid and sandblast

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties